Medroxyprogesterone Acetate Injection — Class II drug recall D-0463-2022
Ongoing recall by Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy, reported 2022-02-09, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0463-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy, Union, NJ, United States |
| Recall initiated | 2021-12-21 |
| Classified | 2022-01-31 |
| Reported by FDA | 2022-02-09 |
| Distributed | Nationwide (US) |
| Quantity | 57,994 vials |
| Reason classes | sterility |
Product
Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0463-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.